National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Brimonidine 3.3 mg/g gel (Mirvaso®) is indicated for the treatment of facial erythema of rosacea in adult patients.

 Rapid Review

Commenced Completed Outcome
09/04/2014 06/052014 Full Pharmacoeconomic Evaluation Not Recommended